Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761094
11 Oct 2023
// ECONOMIC TIMES
https://www.indianpharmapost.com/news/eni-and-dompe-farmaceutici-join-forces-for-health-research-14773
10 Oct 2023
// BUSINESSWIRE
30 Nov 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/dompe-new-published-data-point-to-spike-protein-interactions-with-estrogen-receptors-as-a-cause-for-coagulopathy-in-covid-19-patients-signaling-sex-effects-and-a-path-to-improved-vaccines-301690590.html
26 Jul 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/two-clinical-studies-to-treat-mild-to-moderate-covid-19-at-home-reveal-value-of-exscalate-dompes-ai-platform-for-drug-design-301592560.html
13 Jun 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/dompe-announces-results-of-phase-2-study-evaluating-the-efficacy-and-safety-of-reparixin-in-patients-with-severe-covid-19-pneumonia-301566589.html
Regulatory Info :
Registration Country : Italy
Dosage Form : Suspension For Nebulizer
Brand Name : READY
Dosage Strength : 800 micrograms
Packaging : 20 UNITS 800 MCG - RESPIRATORY USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Beclomethasone 0,8Mg 20 ...
Brand Name : Prontinal
Dosage Strength : suspe nebul 20 vials 0...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Film-Coated Tablets
Brand Name : SEQUACOR
Dosage Strength : 3.75 mg
Packaging : 28 UNITS 3.75 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Film-Coated Tablets
Brand Name : SEQUACOR
Dosage Strength : 7.5 mg
Packaging : 28 UNITS 7.5 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Film-Coated Tablets
Brand Name : SEQUACOR
Dosage Strength : 1.25 mg
Packaging : 28 UNITS 1.25 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Film-Coated Tablets
Brand Name : SEQUACOR
Dosage Strength : 10 mg
Packaging : 28 UNITS 10 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Film-Coated Tablets
Brand Name : SEQUACOR
Dosage Strength : 5 mg
Packaging : 28 UNITS 5 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Film-Coated Tablet
Brand Name : SEQUACOR
Dosage Strength : 2.5mg
Packaging : 28 UNITS 2.5 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Tablets
Brand Name : COMPETITION
Dosage Strength : 10 mg
Packaging : 28 UNITS 10 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : USA
Dosage Form : SOLUTION;OPHTHALMIC
Brand Name : OXERVATE
Dosage Strength : 0.002%(20MCG/ML)
Packaging :
Approval Date :
Application Number : 761094
Regulatory Info :
Registration Country : USA
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?